Home NDC 68788-0768 CELEBREX
Product NDC 68788-0768
11-digit product format 687880768
Labeler code 68788
Product ID 68788-0768_e082d783-793f-4c17-b124-04fe377fb272
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Celecoxib
Dosage form CAPSULE
Route ORAL
Labeler Preferred Pharmaceuticals, Inc.
Application NDA020998
Marketing category NDA
Marketing start 2014-08-20
Marketing end 0000-00-00
Substance CELECOXIB
Active strength 200 mg/1
Pharmacologic classes Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 68788-0768-3 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 68788-0768-3 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 68788-0768-3 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 68788-0768-3 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 68788-0768-3 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 68788-0768-3 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 68788-0768-3 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 68788-0768-3 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 68788-0768-3 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 68788-0768-3 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 68788-0768-3 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 68788-0768-3 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 68788-0768-3 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 68788-0768-3 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 68788-0768-3 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 68788-0768-3 fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 68788-0768-3 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 68788-0768-3 bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 68788-0768-3 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 68788-0768-3 e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 68788-0768-3 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 68788-0768-3 110d247fa046…a55b01930146…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020998-001 CELEBREX CELECOXIB 100MG CAPSULE / ORAL AB RLD 1998-12-31 N020998-002 CELEBREX CELECOXIB 200MG CAPSULE / ORAL AB RLD 1998-12-31 N020998-003 CELEBREX CELECOXIB 400MG CAPSULE / ORAL AB RLD, RS 2002-08-29 N020998-004 CELEBREX CELECOXIB 50MG CAPSULE / ORAL AB RLD 2006-12-15
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N020998-001 CELEBREX 100MG CAPSULE / ORAL AB RLD 1998-12-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020998-002 CELEBREX 200MG CAPSULE / ORAL AB RLD 1998-12-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020998-003 CELEBREX 400MG CAPSULE / ORAL AB RLD, RS 2002-08-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020998-004 CELEBREX 50MG CAPSULE / ORAL AB RLD 2006-12-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020998-001 CELEBREX 100MG CAPSULE / ORAL AB RLD 1998-12-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020998-002 CELEBREX 200MG CAPSULE / ORAL AB RLD 1998-12-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020998-003 CELEBREX 400MG CAPSULE / ORAL AB RLD, RS 2002-08-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020998-004 CELEBREX 50MG CAPSULE / ORAL AB RLD 2006-12-15 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020998-001 CELEBREX 100MG CAPSULE / ORAL AB RLD 1998-12-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020998-002 CELEBREX 200MG CAPSULE / ORAL AB RLD 1998-12-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020998-003 CELEBREX 400MG CAPSULE / ORAL AB RLD, RS 2002-08-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020998-004 CELEBREX 50MG CAPSULE / ORAL AB RLD 2006-12-15 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020998-001 CELEBREX 100MG CAPSULE / ORAL AB RLD 1998-12-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020998-002 CELEBREX 200MG CAPSULE / ORAL AB RLD 1998-12-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020998-003 CELEBREX 400MG CAPSULE / ORAL AB RLD, RS 2002-08-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020998-004 CELEBREX 50MG CAPSULE / ORAL AB RLD 2006-12-15 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020998-001 CELEBREX 100MG CAPSULE / ORAL AB RLD 1998-12-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020998-002 CELEBREX 200MG CAPSULE / ORAL AB RLD 1998-12-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020998-003 CELEBREX 400MG CAPSULE / ORAL AB RLD, RS 2002-08-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020998-004 CELEBREX 50MG CAPSULE / ORAL AB RLD 2006-12-15 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020998-001 CELEBREX 100MG CAPSULE / ORAL AB RLD 1998-12-31 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020998-002 CELEBREX 200MG CAPSULE / ORAL AB RLD 1998-12-31 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020998-003 CELEBREX 400MG CAPSULE / ORAL AB RLD, RS 2002-08-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020998-004 CELEBREX 50MG CAPSULE / ORAL AB RLD 2006-12-15 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020998-001 CELEBREX 100MG CAPSULE / ORAL AB RLD 1998-12-31 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020998-002 CELEBREX 200MG CAPSULE / ORAL AB RLD 1998-12-31 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020998-003 CELEBREX 400MG CAPSULE / ORAL AB RLD, RS 2002-08-29 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020998-004 CELEBREX 50MG CAPSULE / ORAL AB RLD 2006-12-15 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020998-001 CELEBREX 100MG CAPSULE / ORAL AB RLD 1998-12-31 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020998-002 CELEBREX 200MG CAPSULE / ORAL AB RLD 1998-12-31 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020998-003 CELEBREX 400MG CAPSULE / ORAL AB RLD, RS 2002-08-29 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020998-004 CELEBREX 50MG CAPSULE / ORAL AB RLD 2006-12-15 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020998-001 CELEBREX 100MG CAPSULE / ORAL AB RLD 1998-12-31 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020998-002 CELEBREX 200MG CAPSULE / ORAL AB RLD 1998-12-31 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020998-003 CELEBREX 400MG CAPSULE / ORAL AB RLD, RS 2002-08-29 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020998-004 CELEBREX 50MG CAPSULE / ORAL AB RLD 2006-12-15 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020998-001 CELEBREX 100MG CAPSULE / ORAL AB RLD 1998-12-31 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020998-002 CELEBREX 200MG CAPSULE / ORAL AB RLD 1998-12-31 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020998-003 CELEBREX 400MG CAPSULE / ORAL AB RLD, RS 2002-08-29 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020998-004 CELEBREX 50MG CAPSULE / ORAL AB RLD 2006-12-15 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 164 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 68788-0768-3 CELEBREX 30 in 1 BOTTLE CAPSULE 30 1
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CELECOXIB ACTIVE INGREDIENT JCX84Q7J1L CELEBREX (CELECOXIB) CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 1 CELECOXIB ACTIVE MOIETY JCX84Q7J1L CELEBREX (CELECOXIB) CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 1 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 CELEBREX (CELECOXIB) CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 1 GELATIN INACTIVE INGREDIENT 2G86QN327L CELEBREX (CELECOXIB) CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 1 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X CELEBREX (CELECOXIB) CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 CELEBREX (CELECOXIB) CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 1 POVIDONES INACTIVE INGREDIENT FZ989GH94E CELEBREX (CELECOXIB) CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 1 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J CELEBREX (CELECOXIB) CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 68788-0768 CELEBREX (CELECOXIB) CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 1 Legacy NDC, 1 package rows 20140821_e082d783-793f-4c17-b124-04fe377fb272.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join CELEBREX CELECOXIB Viatris Specialty LLC 2d6675e4-5859-4be2-8037-a20ce9f707aa 2024-11-22 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 020998 application number: NDA020998
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 68788-0768-3 68788076803 30 in 1 BOTTLE Historical